EE03483B1 - 4-aminotetrahüdrobensisoksasooli või -isotiasooli ühendid, nende kasutamine farmatseutiliste preparaatide valmistamiseks ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid - Google Patents

4-aminotetrahüdrobensisoksasooli või -isotiasooli ühendid, nende kasutamine farmatseutiliste preparaatide valmistamiseks ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE03483B1
EE03483B1 EE9700197A EE9700197A EE03483B1 EE 03483 B1 EE03483 B1 EE 03483B1 EE 9700197 A EE9700197 A EE 9700197A EE 9700197 A EE9700197 A EE 9700197A EE 03483 B1 EE03483 B1 EE 03483B1
Authority
EE
Estonia
Prior art keywords
benzisoxazole
tetrahydro
amino
preparation
compositions containing
Prior art date
Application number
EE9700197A
Other languages
English (en)
Other versions
EE9700197A (et
Inventor
Kristian Perregaard Jens
Sibylle Moltzen Lenz
Falch Erik
Schousboe Arne
Krogsgaard-Larsen Povl
Fr�lund Bente
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of EE9700197A publication Critical patent/EE9700197A/et
Publication of EE03483B1 publication Critical patent/EE03483B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nozzles (AREA)
EE9700197A 1995-02-28 1996-02-28 4-aminotetrahüdrobensisoksasooli või -isotiasooli ühendid, nende kasutamine farmatseutiliste preparaatide valmistamiseks ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid EE03483B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK20795 1995-02-28
PCT/DK1996/000084 WO1996026929A1 (en) 1995-02-28 1996-02-28 4-aminotetrahydrobenzisoxazole or -isothiazole compounds

Publications (2)

Publication Number Publication Date
EE9700197A EE9700197A (et) 1998-02-16
EE03483B1 true EE03483B1 (et) 2001-08-15

Family

ID=8090951

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700197A EE03483B1 (et) 1995-02-28 1996-02-28 4-aminotetrahüdrobensisoksasooli või -isotiasooli ühendid, nende kasutamine farmatseutiliste preparaatide valmistamiseks ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid

Country Status (31)

Country Link
US (2) US5998613A (et)
EP (1) EP0812318B1 (et)
JP (1) JPH11501016A (et)
KR (1) KR100242675B1 (et)
CN (1) CN1087290C (et)
AT (1) ATE317391T1 (et)
AU (1) AU697610B2 (et)
BG (1) BG63258B1 (et)
BR (1) BR9607443A (et)
CA (1) CA2213127A1 (et)
CZ (1) CZ290837B6 (et)
DE (1) DE69635798T2 (et)
DK (1) DK0812318T3 (et)
EA (1) EA000380B1 (et)
EE (1) EE03483B1 (et)
ES (1) ES2253748T3 (et)
FI (1) FI973519A0 (et)
HK (1) HK1008527A1 (et)
HU (1) HUP9800631A3 (et)
IL (1) IL117295A (et)
IS (1) IS2352B (et)
NO (1) NO309474B1 (et)
NZ (1) NZ301653A (et)
PL (1) PL187404B1 (et)
RO (1) RO119545B1 (et)
SI (1) SI0812318T1 (et)
SK (1) SK281879B6 (et)
TR (1) TR199700873T1 (et)
UA (1) UA43396C2 (et)
WO (1) WO1996026929A1 (et)
ZA (1) ZA961591B (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
GB9622370D0 (en) * 1996-10-28 1997-01-08 Merck Sharp & Dohme Therapeutic agents
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
CA2759598C (en) * 2009-05-05 2017-09-12 F. Hoffmann-La Roche Ag Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders
WO2010151711A1 (en) 2009-06-25 2010-12-29 Alkermes, Inc. Prodrugs of nh-acidic compounds
CN105758807B (zh) * 2016-02-22 2019-01-29 山东出入境检验检疫局检验检疫技术中心 一种鉴别废润滑油的方法
AU2019230014A1 (en) 2018-03-05 2020-09-17 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602643C2 (de) * 1976-01-24 1984-12-20 Bayer Ag, 5090 Leverkusen 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4514414A (en) * 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
US4804663A (en) 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
US5321037A (en) * 1986-12-26 1994-06-14 Sankyo Company, Limited Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants
ZA879631B (en) * 1986-12-26 1989-08-30 Sankyo Co Centrally-acting muscle relaxants
US5225412A (en) * 1991-04-29 1993-07-06 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides

Also Published As

Publication number Publication date
SK115197A3 (en) 1998-02-04
NO973948L (no) 1997-08-27
JPH11501016A (ja) 1999-01-26
EP0812318A1 (en) 1997-12-17
RO119545B1 (ro) 2004-12-30
UA43396C2 (uk) 2001-12-17
HUP9800631A2 (hu) 1998-08-28
IS2352B (is) 2008-04-15
BG63258B1 (bg) 2001-07-31
NO309474B1 (no) 2001-02-05
BG101894A (en) 1998-05-29
CN1087290C (zh) 2002-07-10
US6174909B1 (en) 2001-01-16
KR19980702546A (ko) 1998-07-15
HK1008527A1 (en) 1999-07-30
ZA961591B (en) 1996-08-28
ES2253748T3 (es) 2006-06-01
BR9607443A (pt) 1998-05-26
CN1176638A (zh) 1998-03-18
DE69635798D1 (de) 2006-04-20
CZ271197A3 (cs) 1998-03-18
DE69635798T2 (de) 2006-08-17
IL117295A (en) 1999-11-30
TR199700873T1 (xx) 1998-01-21
EA000380B1 (ru) 1999-06-24
SK281879B6 (sk) 2001-08-06
HUP9800631A3 (en) 1998-12-28
US5998613A (en) 1999-12-07
IL117295A0 (en) 1996-06-18
MX9706280A (es) 1998-06-30
FI973519A (fi) 1997-08-27
NO973948D0 (no) 1997-08-27
PL321956A1 (en) 1998-01-05
CA2213127A1 (en) 1996-09-06
EA199700199A1 (ru) 1998-02-26
ATE317391T1 (de) 2006-02-15
EP0812318B1 (en) 2006-02-08
IS4542A (is) 1997-08-13
PL187404B1 (pl) 2004-07-30
WO1996026929A1 (en) 1996-09-06
DK0812318T3 (da) 2006-06-06
NZ301653A (en) 1998-12-23
FI973519A0 (fi) 1997-08-27
CZ290837B6 (cs) 2002-10-16
AU697610B2 (en) 1998-10-15
EE9700197A (et) 1998-02-16
AU4713196A (en) 1996-09-18
KR100242675B1 (ko) 2000-03-02
SI0812318T1 (sl) 2006-06-30

Similar Documents

Publication Publication Date Title
MX9203053A (es) Derivados de aza nor bornano.
BR0314721A (pt) Compostos tricìclicos úteis para tratamento de distúrbios inflamatórios e alérgicos, processo para sua preparação e composições farmacêuticas contendo-os
ATE172963T1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
IL108769A0 (en) Spirocyclic piperidine derivatives
DK0792268T3 (da) Hypolipidæmiske benzothiazepiner
BRPI0409109A (pt) novos compostos
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
EE03483B1 (et) 4-aminotetrahüdrobensisoksasooli või -isotiasooli ühendid, nende kasutamine farmatseutiliste preparaatide valmistamiseks ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid
TNSN99080A1 (fr) Composes azapolycycliques condenses a noyau aryle, procede pour leur preparation et compositions pharmaceutiques les contenant
HUP0001093A2 (hu) 5-HT2A-antagonista oxazolidinon-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
IL136306A (en) Bis (fluorophenyl) alkylamides and related compounds, pharmaceutical compositions comprising them and their use in treating neurological disease or disorder
HUP9801759A2 (hu) Neurodegeneratív betegségek kezelésére alkalmas benzamidok

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

MM4A Lapsed by not paying the annual fees

Effective date: 20100228